SAB Biotherapeutics annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
SAB Biotherapeutics Capital Expenditures (CapEx) Growth & History (SABS)
SAB Biotherapeutics's capital expenditures (capex) was $933,156 for fiscal 2025.
View full SAB Biotherapeutics company overviewSAB Biotherapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $933,156 | $595,894 | +176.69% |
| 2024 | 2024-12-31 | $337,262 | $140,108 | +71.07% |
| 2023 | 2023-12-31 | $197,154 | −$2.0M | −90.90% |
| 2022 | 2022-12-31 | $2.2M | −$8.8M | −80.20% |
| 2021 | 2021-12-31 | $10.9M | −$1.8M | −14.04% |
| 2020 | 2020-12-31 | $12.7M | — | — |
SAB Biotherapeutics quarterly capital expenditures (capex)
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.6M | — | — |
| Q1 2026 | 2026-03-31 | $983,257 | — | — |
| Q4 2024 | 2024-12-31 | $55,377 | −$12,487 | −18.40% |
| Q3 2024 | 2024-09-30 | $100,300 | $14,994 | +17.58% |
| Q2 2024 | 2024-06-30 | $52,511 | $29,827 | +131.49% |
| Q1 2024 | 2024-03-31 | $129,074 | $107,774 | +505.98% |
| Q4 2023 | 2023-12-31 | $67,864 | −$49,890 | −42.37% |
| Q3 2023 | 2023-09-30 | $85,306 | $6,802 | +8.66% |
| Q2 2023 | 2023-06-30 | $22,684 | −$590,148 | −96.30% |
| Q1 2023 | 2023-03-31 | $21,300 | −$1.3M | −98.43% |
| Q4 2022 | 2022-12-31 | $117,754 | −$2.2M | −95.01% |
| Q3 2022 | 2022-09-30 | $78,504 | −$3.1M | −97.57% |
| Q2 2022 | 2022-06-30 | $612,832 | −$2.9M | −82.31% |
| Q1 2022 | 2022-03-31 | $1.4M | −$532,832 | −28.19% |
| Q4 2021 | 2021-12-31 | $2.4M | — | — |
| Q3 2021 | 2021-09-30 | $3.2M | — | — |
| Q2 2021 | 2021-06-30 | $3.5M | — | — |
| Q1 2021 | 2021-03-31 | $1.9M | — | — |
SAB Biotherapeutics capital expenditures (capex) trends
Over the last five fiscal years, SAB Biotherapeutics's capital expenditures (capex) decreased from $12.7M to $933,156, a change of −$11.8M. The latest reported quarter, Q2 2026, shows $1.6M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SAB Biotherapeutics source filings ↗